Spermidine Coating on Implants Slashes Inflammation and Boosts Bone Integration

Medical implants — from silicone breast prostheses to titanium bone scaffolds — trigger a foreign body response (FBR) in which the host immune system attacks and encapsulates the device in fibrous tissue. This chronic inflammation and fibrosis can impair healing, reduce bone integration, and ultimately cause implant failure. Current countermeasures, such as dexamethasone coatings or cytokine injections, carry side effects, high costs, or logistical drawbacks. This study proposes spermidine (SPD), a naturally occurring polyamine found in high concentrations in seminal fluid — where it evolved to protect sperm from immune attack — as a safer, biologically elegant solution.

The team fabricated a double-network biomatrix called CST@GOA from gelatin, O-carboxymethyl chitosan, and sodium alginate, crosslinked first with a spermidine-terephthaladehyde (ST) Schiff base crosslinker, then ionically with calcium chloride. This structure mimics the extracellular matrix. As an 'operando' chemical control, diethylenetriamine (DETA) — a synthetic polyamine sharing structural features with spermidine — was used in parallel experiments to isolate spermidine's unique contributions. The biomatrix was also infused into 3D-printed porous titanium alloy (Ti-6Al-4V) scaffolds with triply periodic minimal surface (TPMS) geometry.

In vitro, CST@GOA suppressed LPS-induced M1 macrophage polarization, reducing TNF-α and IL-6 secretion while increasing anti-inflammatory IL-10. It also inhibited RANKL-driven osteoclastogenesis. Simultaneously, it promoted MC3T3-E1 pre-osteoblast migration and differentiation, enhancing alkaline phosphatase activity and mineral deposition. The DETA analog (CDT@GOA) showed weaker or negligible effects, confirming spermidine's specific bioactivity rather than generic amine chemistry.

In a rat subcutaneous silicone implant model, CST@GOA-coated silicone produced significantly thinner fibrous capsules, fewer infiltrating macrophages, and reduced collagen deposition at 4 and 8 weeks compared to uncoated or DETA-coated controls. In a rabbit femoral defect model, titanium scaffolds interpenetrated with CST@GOA demonstrated superior new bone formation and trabecular connectivity by micro-CT and histological analysis, with reduced peri-implant inflammation markers.

Proteomic profiling of rabbit bone tissue revealed that spermidine upregulates PTEN, a phosphatase that negatively regulates the PI3K-Akt pathway. This modulation appears to coordinately dampen inflammatory signaling, promote autophagy, and support bone homeostasis — providing a mechanistic framework for spermidine's multi-pronged benefits. The authors propose that spermidine's natural role in protecting sperm from immune rejection offers a direct biological precedent for its use in implant immunomodulation.